Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
CRL · NYSE · Life Sciences Tools & Services
$333.25+1.09 (+0.33%)
Close of Nov 18, 2026, vs Nov 17 · end-of-day, not a live quote
Charles River Laboratories (CRL) · oqro.io/stocks/CRL · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
Bridgewater Associates disclosed a new position in CRL for Q3 2026Source5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
T. Rowe Price Associates, Inc. now owns 6.3% of CRL as a passive investorSourceInsider trade · Traded Oct 22, 2026 · Filed Oct 26, 2026
Director sold ~$8.41M of CRL shares in the open marketSourceInsider trade · Traded Oct 21, 2026 · Filed Oct 23, 2026
Officer sold ~$743K of CRL shares in the open marketSourcePlanned sale · Planned for Oct 22, 2026 · Notice filed Oct 22, 2026
Director filed to sell about $8.41M of CRL stockSourcePlanned sale · Planned for Oct 21, 2026 · Notice filed Oct 21, 2026
Officer filed to sell about $743K of CRL stockSourceInsider trade · Traded Oct 5, 2026 · Filed Oct 8, 2026
Officer sold ~$303K of CRL shares in the open marketSourcePlanned sale · Planned for Oct 5, 2026 · Notice filed Oct 5, 2026
Officer filed to sell about $309K of CRL stockSourceFederal contract · Signed Aug 31, 2026 · Updated Sep 28, 2026
Department of Health and Human Services awarded Charles River Laboratories: $1.01M obligated to dateSourceFederal contract · Signed Sep 25, 2026 · Updated Sep 25, 2026
Department of Health and Human Services awarded Charles River Laboratories: $340K obligated to dateSourceFederal contract · Signed Sep 17, 2026 · Updated Sep 17, 2026
Department of Health and Human Services awarded Charles River Laboratories: $8.25M obligated to dateSourceFederal contract · Signed Sep 17, 2026 · Updated Sep 17, 2026
Department of Health and Human Services awarded Charles River Laboratories: $2.68M obligated to dateFederal contract · Signed Feb 28, 2026 · Updated Aug 31, 2026
Department of Health and Human Services awarded Charles River Laboratories: $5.31M obligated to dateSourceInsider trade · Traded Aug 25, 2026 · Filed Aug 27, 2026
Director sold ~$10.1M of CRL shares in the open marketSourceInsider trade · Traded Aug 18, 2026 · Filed Aug 20, 2026
Director sold ~$163K of CRL shares in the open marketSourceInsider trade · Traded Aug 19, 2026 · Filed Aug 20, 2026
Officer sold ~$600K of CRL shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 30, 2026
Cooke & Bieler LP disclosed a reduced position in CRL for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 24, 2026
Boston Trust Walden Corp disclosed an increased position in CRL for Q2 2026SourceInsider trade · Traded Jun 29, 2026 · Filed Jul 1, 2026
Director sold ~$16.9M of CRL shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 1, 2026
Confluence Investment Management LLC disclosed a reduced position in CRL for Q2 2026Federal contract · Signed Feb 25, 2026 · Updated Jun 23, 2026
Department of Health and Human Services awarded Charles River Laboratories: $936K obligated to dateSourceFederal contract · Signed Jun 1, 2026 · Updated Jun 1, 2026
Department of Health and Human Services awarded Charles River Laboratories: $340K obligated to dateSourceFederal contract · Signed Jun 1, 2026 · Updated Jun 1, 2026
Department of Health and Human Services awarded Charles River Laboratories: $340K obligated to dateSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Soros Fund Management no longer reported CRL for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Ilex Capital Partners (UK) LLP disclosed a new position in CRL for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Bridgewater Associates disclosed a reduced position in CRL for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Frontier Capital Management Co LLC disclosed a reduced position in CRL for Q1 2026Fund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 24, 2026
Boston Trust Walden Corp disclosed a reduced position in CRL for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 1, 2026
Confluence Investment Management LLC disclosed a reduced position in CRL for Q1 2026SourceInsider trade · Traded Mar 3, 2026 · Filed Mar 4, 2026
Officer purchased ~$4.4K of CRL shares in the open marketSourceFederal contract · Signed Jan 20, 2026 · Updated Mar 4, 2026
Department of Health and Human Services awarded Charles River Laboratories: $1.92M obligated to dateSourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Longaeva Partners L.P. no longer reported CRL for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Frontier Capital Management Co LLC disclosed an increased position in CRL for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Harris Associates L P disclosed an increased position in CRL for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Soros Fund Management disclosed a new position in CRL for Q4 2025Insider trade · Traded Aug 22, 2025 · Filed Jan 20, 2026
Officer sold ~$65K of CRL shares in the open marketSourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Jan 5, 2026
Confluence Investment Management LLC disclosed an increased position in CRL for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Longaeva Partners L.P. disclosed a new position in CRL for Q3 2025Source5%+ stake · Stake as of Sep 30, 2025 · Filed Nov 14, 2025
NOMURA HOLDINGS INC cut its CRL stake below 5% (1.6%)SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Perceptive Advisors LLC no longer reported CRL for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Junto Capital Management LP no longer reported CRL for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Oct 29, 2025
Mizuho Markets Americas LLC disclosed a new position in CRL for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Oct 17, 2025
Boston Trust Walden Corp disclosed an increased position in CRL for Q3 2025SourceInsider trade · Traded Aug 18, 2025 · Filed Aug 20, 2025
Officer sold ~$126K of CRL shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Perceptive Advisors LLC disclosed a new position in CRL for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Junto Capital Management LP disclosed a new position in CRL for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Harris Associates L P disclosed a new position in CRL for Q2 2025Federal contract · Signed Aug 18, 2026 · Updated Sep 1, 2026
Department of Health and Human Services awarded Charles River Laboratories: $372K obligated to dateSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Perceptive Advisors LLC disclosed a new position in CRL for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
SRS Investment Management, LLC disclosed a new position in CRL for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Ariel Investments, LLC disclosed an increased position in CRL for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Bridgewater Associates no longer reported CRL for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Ilex Capital Partners (UK) LLP disclosed a reduced position in CRL for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Alyeska Investment Group, L.P. disclosed a reduced position in CRL for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Harris Associates L P disclosed an increased position in CRL for Q2 2026SourceInsider trade · Traded Aug 11, 2026 · Filed Aug 13, 2026
CEO sold ~$1.82M of CRL shares in the open marketSourceInsider trade · Traded Aug 11, 2026 · Filed Aug 13, 2026
Officer sold ~$1.04M of CRL shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 13, 2026
Snyder Capital Management L P disclosed an increased position in CRL for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 13, 2026
Earnest Partners LLC disclosed an increased position in CRL for Q2 2026SourceInsider trade · Traded Aug 10, 2026 · Filed Aug 11, 2026
Director sold ~$7.9M of CRL shares in the open marketSourceInsider trade · Traded Aug 6, 2026 · Filed Aug 10, 2026
Officer sold ~$1.08M of CRL shares in the open marketSourceInsider trade · Traded Aug 6, 2026 · Filed Aug 10, 2026
Officer sold ~$330K of CRL shares in the open marketSourceInsider trade · Traded Aug 6, 2026 · Filed Aug 10, 2026
Officer sold ~$312K of CRL shares in the open marketSourceInsider trade · Traded Aug 6, 2026 · Filed Aug 10, 2026
Officer sold ~$235K of CRL shares in the open marketSourceInsider trade · Traded Aug 6, 2026 · Filed Aug 10, 2026
Officer sold ~$212K of CRL shares in the open marketSourceInsider trade · Traded Aug 6, 2026 · Filed Aug 10, 2026
Officer sold ~$190K of CRL shares in the open marketSourceInsider trade · Traded Aug 6, 2026 · Filed Aug 10, 2026
Officer sold ~$164K of CRL shares in the open marketSourceInsider trade · Traded Aug 6, 2026 · Filed Aug 10, 2026
Officer sold ~$128K of CRL shares in the open marketSourceInsider trade · Traded Aug 6, 2026 · Filed Aug 10, 2026
Officer sold ~$104K of CRL shares in the open marketSourceInsider trade · Traded Aug 6, 2026 · Filed Aug 10, 2026
Officer sold ~$56K of CRL shares in the open marketSourceInsider trade · Traded Aug 5, 2026 · Filed Aug 6, 2026
Officer sold ~$1.33M of CRL shares in the open marketSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Harris Associates L P disclosed an increased position in CRL for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Earnest Partners LLC disclosed a reduced position in CRL for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Alyeska Investment Group, L.P. disclosed a reduced position in CRL for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Ariel Investments, LLC disclosed an increased position in CRL for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Snyder Capital Management L P disclosed a reduced position in CRL for Q1 2026Source5%+ stake · Stake as of Mar 31, 2026 · Filed May 6, 2026
FMR LLC now owns 7% of CRL as a passive investorSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 4, 2026
Cooke & Bieler LP disclosed an increased position in CRL for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Ariel Investments, LLC disclosed a reduced position in CRL for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Bridgewater Associates disclosed an increased position in CRL for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Alyeska Investment Group, L.P. disclosed an increased position in CRL for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 12, 2026
Snyder Capital Management L P disclosed an increased position in CRL for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 12, 2026
Earnest Partners LLC disclosed a reduced position in CRL for Q4 2025Source5%+ stake · Stake as of Dec 31, 2025 · Filed Feb 10, 2026
Wellington Management Group LLP cut its CRL stake below 5% (3.6%)SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 6, 2026
Mizuho Markets Americas LLC no longer reported CRL for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Ariel Investments, LLC disclosed an increased position in CRL for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
DF Dent & Co Inc disclosed a reduced position in CRL for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Harris Associates L P disclosed an increased position in CRL for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 13, 2025
Bridgewater Associates disclosed a new position in CRL for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 13, 2025
Nearwater Capital Markets, Ltd no longer reported CRL for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 12, 2025
Snyder Capital Management L P disclosed a reduced position in CRL for Q3 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Fuller & Thaler Asset Management, Inc. disclosed a new position in CRL for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Ariel Investments, LLC disclosed an increased position in CRL for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
D1 Capital Partners L.P. no longer reported CRL for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
DF Dent & Co Inc disclosed an increased position in CRL for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 13, 2025
Nearwater Capital Markets, Ltd disclosed a new position in CRL for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 13, 2025
Kennedy Capital Management LLC disclosed a reduced position in CRL for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 12, 2025
Snyder Capital Management L P disclosed an increased position in CRL for Q2 2025SourceInsider trade · Traded Aug 7, 2025 · Filed Aug 8, 2025
Officer sold ~$60K of CRL shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 4, 2025
Cooke & Bieler LP disclosed an increased position in CRL for Q2 2025Source